In this study, we have highlighted the role of the Mediator subunit 12 (MED12) in this process as MED12 is frequently mutated in prostate cancer and has previously been linked to regulation of SHH signaling [25, 26]. This evidence concerns the gene MED12 and prostate carcinoma.